SENTINELONE, INC (S) Spending and interest coverage
- R&D / revenue · 12 months: Value 33.24%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 29.31%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 33.24% | Research and development expense / revenue. Period ending 2026-07-31. $365.16M ÷ $1.10B × 100 ≈ 33.24% |
| Stock-based compensation / revenue · 12 months | 29.31% | Share-based compensation / revenue. Period ending 2026-07-31. $322.05M ÷ $1.10B × 100 ≈ 29.31% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 365.16M USD | Research and Development Expense |
| Revenue | 1.10B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 322.05M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -323.69M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $365.16M | $1.10B | $322.05M | $-323.69M | (m) | 33.24% | 29.31% | (m) | (m) |
| 2026-04-30 | $347.37M | $1.05B | $303.82M | $-313.54M | (m) | 33.12% | 28.97% | (m) | (m) |
| 2026-01-31 | $323.85M | $1.00B | $297.59M | $-321.31M | (m) | 32.34% | 29.72% | (m) | (m) |
| 2025-10-31 | $309.12M | $955.65M | $291.99M | $-321.67M | (m) | 32.35% | 30.55% | (m) | (m) |
| 2025-07-31 | $296.42M | $907.38M | $286.84M | $-337.48M | (m) | 32.67% | 31.61% | (m) | (m) |
| 2025-04-30 | $280.93M | $864.13M | $277.63M | $-336.24M | (m) | 32.51% | 32.13% | (m) | (m) |
| 2025-01-31 | $267.00M | $821.46M | $267.53M | $-329.36M | (m) | 32.50% | 32.57% | (m) | (m) |
| 2024-10-31 | $248.82M | $770.12M | $246.98M | $-330.31M | (m) | 32.31% | 32.07% | (m) | (m) |
| 2024-07-31 | $230.68M | $723.63M | $231.71M | $-322.66M | (m) | 31.88% | 32.02% | (m) | (m) |
| 2024-04-30 | $221.23M | $674.12M | $219.87M | $-343.64M | $645.00K | 32.82% | 32.62% | -532.77× | Reported |
| 2024-01-31 | $218.18M | $621.15M | $216.87M | $-378.42M | $1.22M | 35.12% | 34.91% | -311.20× | Reported |
| 2023-10-31 | $215.63M | $573.08M | $209.46M | $-397.23M | $1.82M | 37.63% | 36.55% | -218.50× | Reported |
| 2023-07-31 | $215.56M | $524.23M | $200.23M | $-419.82M | $2.43M | 41.12% | 38.19% | -172.77× | Reported |
| 2023-04-30 | $216.39M | $477.32M | $188.38M | $-427.66M | $2.43M | 45.33% | 39.47% | -175.85× | Reported |
| 2023-01-31 | $207.01M | $422.18M | $164.47M | $-402.58M | $1.83M | 49.03% | 38.96% | -219.99× | Reported |
| 2022-10-31 | $195.75M | $361.72M | $144.01M | $-373.64M | $1.23M | 54.12% | 39.81% | -304.51× | Reported |
| 2022-07-31 | $178.29M | $302.41M | $125.69M | $-336.95M | $617.00K | 58.95% | 41.56% | -546.12× | Reported |
| 2022-04-30 | $154.34M | $245.66M | $106.08M | $-295.92M | $489.00K | 62.82% | 43.18% | -605.15× | Reported |
| 2022-01-31 | $136.27M | $204.80M | $87.89M | $-267.23M | $787.00K | 66.54% | 42.91% | -339.56× | Reported |
| 2021-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-31 | $62.44M | $93.06M | $15.91M | $-115.52M | $1.40M | 67.10% | 17.10% | -82.45× | Reported |
| 2020-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-01-31 | $36.68M | $46.47M | $4.35M | $-74.98M | $2.02M | 78.93% | 9.35% | -37.21× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.